1. Home
  2. SPTN vs CSTL Comparison

SPTN vs CSTL Comparison

Compare SPTN & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPTN
  • CSTL
  • Stock Information
  • Founded
  • SPTN 1917
  • CSTL 2007
  • Country
  • SPTN United States
  • CSTL United States
  • Employees
  • SPTN N/A
  • CSTL N/A
  • Industry
  • SPTN Food Distributors
  • CSTL Medical Specialities
  • Sector
  • SPTN Consumer Discretionary
  • CSTL Health Care
  • Exchange
  • SPTN Nasdaq
  • CSTL Nasdaq
  • Market Cap
  • SPTN 686.2M
  • CSTL 576.3M
  • IPO Year
  • SPTN N/A
  • CSTL 2019
  • Fundamental
  • Price
  • SPTN $19.94
  • CSTL $18.76
  • Analyst Decision
  • SPTN Hold
  • CSTL Strong Buy
  • Analyst Count
  • SPTN 1
  • CSTL 6
  • Target Price
  • SPTN $20.00
  • CSTL $40.00
  • AVG Volume (30 Days)
  • SPTN 287.3K
  • CSTL 493.6K
  • Earning Date
  • SPTN 02-12-2025
  • CSTL 05-01-2025
  • Dividend Yield
  • SPTN 4.39%
  • CSTL N/A
  • EPS Growth
  • SPTN N/A
  • CSTL N/A
  • EPS
  • SPTN 0.01
  • CSTL 0.62
  • Revenue
  • SPTN $9,549,324,000.00
  • CSTL $332,069,000.00
  • Revenue This Year
  • SPTN $5.82
  • CSTL N/A
  • Revenue Next Year
  • SPTN N/A
  • CSTL $6.01
  • P/E Ratio
  • SPTN $2,236.50
  • CSTL $30.79
  • Revenue Growth
  • SPTN N/A
  • CSTL 51.09
  • 52 Week Low
  • SPTN $17.30
  • CSTL $16.97
  • 52 Week High
  • SPTN $23.00
  • CSTL $35.84
  • Technical
  • Relative Strength Index (RSI)
  • SPTN 53.72
  • CSTL 25.18
  • Support Level
  • SPTN $19.64
  • CSTL $18.70
  • Resistance Level
  • SPTN $20.66
  • CSTL $20.49
  • Average True Range (ATR)
  • SPTN 0.47
  • CSTL 1.53
  • MACD
  • SPTN -0.06
  • CSTL -0.43
  • Stochastic Oscillator
  • SPTN 47.45
  • CSTL 0.76

About SPTN SpartanNash Company

SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME, among others. The company's test portfolio consists of test offerings to aid clinicians in the diagnosis and treatment of cancers or precancerous diagnoses in the fields of dermatology, gastroenterology, and ophthalmology and a pharmacogenomics ("PGx") test to guide optimal drug treatment for patients diagnosed with depression, anxiety, and other mental health conditions.

Share on Social Networks: